In a recent study, immunohistochemical expression of CD44 was found to be related with aggressive behavior and poor therapeutic response in breast cancer.[19] Similar to that, our findings suggest that upregulation of CD44 was associated with worse prognostic factors such as LN metastasis, distant metastasis, and high-stage. This evidence concerns the gene CD44 and breast carcinoma.